<Record>
<Term>Amonafide L-Malate</Term>
<SemanticType>Pharmacologic Substance</SemanticType>
<ParentTerm>Topoisomerase-II Inhibitor</ParentTerm>
<ClassificationPath>Chemicals_and_Drugs_Kind/Drug, Food, Chemical or Biomedical Material/Pharmacologic Substance/Antineoplastic Agent/DNA Binding Agent/DNA Intercalating Agent/Amonafide L-Malate,/NCIThesaurus/Chemicals_and_Drugs_Kind/Drug, Food, Chemical or Biomedical Material/Pharmacologic Substance/Enzyme Inhibitor/Topoisomerase Inhibitor/Topoisomerase-II Inhibitor/Amonafide L-Malate</ClassificationPath>
<BroaderTerm>Topoisomerase Inhibitor</BroaderTerm>
<BroaderTerm>Chemicals_and_Drugs_Kind</BroaderTerm>
<BroaderTerm>Enzyme Inhibitor</BroaderTerm>
<BroaderTerm>Antineoplastic Agent</BroaderTerm>
<BroaderTerm>NCIThesaurus</BroaderTerm>
<BroaderTerm>Pharmacologic Substance</BroaderTerm>
<BroaderTerm>Amonafide L-Malate</BroaderTerm>
<BroaderTerm>Topoisomerase-II Inhibitor</BroaderTerm>
<BroaderTerm>Amonafide L-Malate,</BroaderTerm>
<BroaderTerm>DNA Intercalating Agent</BroaderTerm>
<BroaderTerm>Drug, Food, Chemical or Biomedical Material</BroaderTerm>
<BroaderTerm>DNA Binding Agent</BroaderTerm>
<Synonym>Amonafide L-Malate</Synonym>
<Synonym>Xanafide</Synonym>
<Description>The malate salt of amonafide, an imide derivative of naphthalic acid, with potential antineoplastic activity. Amonafide intercalates into DNA and inhibits topoisomerase II, resulting in DNA double-strand breaks (DSB) and inhibition of DNA replication and RNA synthesis.</Description>
<Source>NCI Thesaurus</Source>
</Record>
